![]() |
The Third Wheel or the Steering Wheel? Pharmacists on t...
November 1, 2013 - Professional Advice / Opinions By: Joshua Bliss, PharmD Candidate c/o 2016 – Doctor – a word often utilized by both professionals and the general public alike to describe a physician. “Doctor” finds its origins in the Latin word for “teacher.” The word “physician,” however, carries a more complicated origin. It is derived from Latin’s “physicum,” meaning remedy.1 In Luke… |
![]() |
“Cowcatcher” Enzyme Catching Medical Attention...
November 1, 2013 - Featured , In the News / Politics By: Ansel Oommen, BS Toxicology Candidate c/o 2014 – DNA damage is the driving force behind aging, and, on a more serious note, the development of cancers.1 While the stresses of life can be taxing on cells, the human body possesses a remarkable repair mechanism to remedy them. Researchers from the University of Texas Medical… |
![]() |
Ceftriaxone Induced Hemolytic Anemia...
November 1, 2013 - Clinical , Featured By: Samad Tirmizi, PharmD Candidate c/o 2014 – Hemolytic anemia (HA) is a type of anemia that occurs due to the breakdown of red blood cells. It is classified as intrinsic and extrinsic according to causative factors. Medication induced hemolytic anemia is an example of extrinsic, while genetic predisposition is an intrinsic factor. Drug induced… |
![]() |
Accepting the Mantle: The 2013 White Coat Ceremony...
November 1, 2013 - Events By: Davidta Brown – Every year in late October, the third year pharmacy students at the College of Pharmacy and Health Sciences attend a ceremony that marks their entry in the first professional year of their education. For these students, the White Coat Ceremony marks a coming of age and a full acceptance of the… |
![]() |
Does Moxifloxacin Increase the Risk of Dysglycemia?...
November 1, 2013 - Clinical , Featured By: Nathan Trustman, PharmD Candidate c/o 2014, AMSCOP at LIU – The antibiotic class known as the fluoroquinolones is widely used in both outpatient and inpatient settings. They provide bactericidal effects by inhibiting DNA gyrase and topoisomerase IV enzymes in bacteria. The systemic agents that are most commonly used in clinical practice include ciprofloxacin, levofloxacin,… |
![]() |
Nature’s Remedy… in a More Palatable Dosage Form...
November 1, 2013 - Featured , In the News / Politics By: Davidta Brown, Staff Editor – Pathogenic bacteria have been enemies to human health for centuries. As recently as last month, the Centers for Disease Control published an 80-page document informing the public about America’s biggest microbial threats. Most of the pathogens on the list exhibit antibacterial resistance. One particular bacterial species, ranked at threat… |
![]() |
What You Should Know About Selecting APPE Rotations...
October 1, 2013 - Professional Advice / Opinions By: Aleena Cherian, Co-Copy Editor, Graphics Focused – Selecting APPE Rotations You’ve made it past the progression interviews at the end of 2nd year, the White Coat Ceremony, and the mind-boggling compounding and kinetics equations. You’re almost done with those labs and late night D&D study sessions. Now, halfway through the first semester of your… |
![]() |
New Treatment for a Deficiency in Iron-Supplement Thera...
October 1, 2013 - Clinical By: Davidta Brown, Staff Editor – For the estimated 7.5 million individuals in the United States living with iron deficiency anemia (IDA), there is now a new alternative to iron supplements or time-consuming, repetitive infusions. On July 25, 2013, the FDA approved ferric carboxymaltose injection (Injectafer®) for the treatment of IDA, especially in patients who… |
![]() |
New Drug to Treat HIV-1 Hits the Market...
October 1, 2013 - Clinical , Featured By: Ada Seldin, Staff Editor – On August 12,2013, a new weapon against HIV-1 infection was added to the existing armada. Dolutegravir, the third integrase strand transfer inhibitor to attain FDA approval, targets a protein essential to HIV replication. HIV-1 is the predominant type of HIV virus, the other being HIV-2, which is endogenous to… |
![]() |
After 15 Years, First New Recombinant Coagulation Facto...
October 1, 2013 - Clinical By: Tamara Yunusova, Senior Staff Editor – After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor IX (Rixubis) has mounted to the forefront of Hemophilia B drug therapy. The recombinant coagulation factor gained orphan drug approval on June 26, 2013 for routine prophylaxis, control of bleeding episodes, and perioperative management in… |
![]() |
Ketoconazole No More...
October 1, 2013 - Featured , In the News / Politics By: Hayeon Na, Co-Copy Editor [Content-Focused] – The Food and Drug Administration (FDA) announced on July 26th that oral dosage forms of ketoconazole (Nizoral®) should no longer be prescribed as first-line therapy for any fungal infections.1 The label and indication for oral ketoconazole were updated, and a new medication guide was added. Other dosage forms… |
![]() |
Canagliflozin (Invokana®): New Type 2 Diabetes Drug...
October 1, 2013 - Clinical By: Sang Hyo Kim, Staff Editor – On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®), a new form of a diabetic drug for patients with type 2 diabetes mellitus.1 Canagliflozin is in a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors and is the only oral, once-daily… |
![]() |
Hope For Children with Acute Lymphoblastic Leukemia...
October 1, 2013 - Featured , In the News / Politics By: Ada Seldin, Staff Editor – Emily Whitehead, a 7-year-old girl who fought off relapsing acute lymphoblastic leukemia (ALL), has captured the hearts and prayers of the masses. Her story is an inspiration to those battling any disease with a poor prognosis and particularly holds promise for the 15% of children with ALL resistant to… |
![]() |
Meet the Dean: Interview with Dean DiGate...
October 1, 2013 - Featured , Professional Advice / Opinions By: Katharine Cimmino, Editor-in-Chief and Erica Dimitropoulos, Senior Staff Editor – Just last month, St. John’s University College of Pharmacy and Health Sciences kindly welcomed a new Dean into our family, Dean Russell J. DiGate. Dean DiGate is a highly experienced educator and academic leader. He attended the University of Rochester, where… |
![]() |
Nattokinase use in DVT prophylaxis...
October 1, 2013 - Clinical Samad Tirmizi, Pharm. D. Candidate c/o 2014 – Deep vein thrombosis (DVT) is a clot formation that occurs within deep veins, generally in the legs. This can cause swelling and pain due to the engorged vessels, and can eventually result in further complications such as a pulmonary embolism. Patients at high risk for DVT are… |
![]() |
BRAIN Initiative: Mapping the Human Brain...
October 1, 2013 - Featured , In the News / Politics By Erica Dimitropoulos, Senior Staff Editor – If you were in charge of government spending, how would you allocate our funds? Would you put more money into public schools? Restructure the healthcare system? How about a multi-billion dollar project to remap the brain? A few months ago, President Obama announced his plans to invest in… |
![]() |
An Interview with Dr. Barile: Professor, Reseacher, and...
September 1, 2013 - Professional Advice / Opinions By: Katharine Cimmino, Editor-in-Chief & Bharat Kirthivasan, Co-Copy Editor – Frank A. Barile Ph.D. is a Professor of Clinical and Applied Toxicology at St. John’s University. He is also a St. John’s University alumnus, having received a B.S. in Pharmaceutical Science, an M.S. in Toxicology, and a Ph.D. in Pharmacology. At St. John’s University, Dr.… |
![]() |
FDA’s New Warning: Acetaminophen Associated with Seri...
September 1, 2013 - Featured , In the News / Politics By: Andy Zhang, PharmD Candidate c/o 2015 – On August 1st, 2013, the U.S. Food and Drug Administration (FDA) released a new warning of serious acetaminophen associated skin reactions, including Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN) and acute generalized exanthematous pustulosis (AGEP).1 Acetaminophen is one of the most widely used over-the-counter (OTC) medication, and… |
![]() |
Olmesartan Medoxomil Label Revision...
September 1, 2013 - In the News / Politics By: David Ong, PharmD Candidate c/o 2014 – Manipulating the renin-angiotensin system is one of the many ways drugs are used to treat hypertension. By blocking key steps in the renin-angiotensin cascade, blood pressure decrease may be achieved. Angiotensin II receptor blockers (ARBs) represent one of the drug classes that utilize the aforementioned mechanism. ARBs… |
![]() |
HIV Test: Making a Difference...
September 1, 2013 - In the News / Politics By: Sang Hyo Kim, Staff Editor – On June 27, 2013, the Centers for Disease Control and Prevention (CDC), AIDS.gov, and other national and local entities organized the 19th annual National HIV Testing Day. On this day, the theme of “Take the Test, Take Control” was employed to spread awareness of testing and prevention methods… |
![]() |
Novel Virus, Standard Vigilance...
September 1, 2013 - Featured , In the News / Politics By: Davidta Brown, Staff Editor – When the seasons transition from winter into spring every year, healthcare providers brace for a shift into a time of increased sneezes, requests for cough medication, and vaccinations, otherwise known as flu season. The rounds of illness that pass each year are usually more of an annoyance than a… |
![]() |
Children, Codeine, and Cytochrome P-450...
September 1, 2013 - Clinical , Featured By Davidta Brown, Staff Editor – For post-operative pain treatment, few drugs are as trustworthy, as tried-and-true, as codeine. Prescriptive confidence in the analgesic has promoted its use in children recovering from uncomplicated surgeries, but the spate of injuries and deaths of young children who had been given codeine after undergoing adenotonsillectomies has provoked a… |
![]() |
A Close Concurrence on Certolizumab (Cimzia®)...
September 1, 2013 - Clinical , Featured By: Sang Hyo Kim, Staff Editor – This year, on July 23rd, FDA advisers voted 7 to 6, with one abstention, in favor of approving the drug certolizumab (Cimzia®) for the indication of axial spondyloarthritis (axSpA). axSpA is a chronic imflammatory condition that includes ankylosing spondylitis (AS) and non-radiographic axial spndyloarthristis (nr-axSpA).1,2 axSpA, AS and… |
![]() |
Take a Chance!...
August 1, 2013 - Professional Advice / Opinions By: Praneeta Nagraj, PharmD Candidate c/o 2015 – Summer is a great time to recover from the school year through reflection and relaxation, but it’s also the perfect opportunity to develop your career and discover where you belong within the pharmacy profession, which can be realized through work or an internship. What if I told… |
![]() |
iPod, iPad, iPhone… iLimb...
August 1, 2013 - Featured , In the News / Politics By: Sang Hyo Kim, Staff Editor – There is a new invention called “i-limb ultra revolution,” which allows amputees to control their prosthetic hands with an Apple® app called “Bioism.” Designed by Touch Bionics in the United Kingdom, the new prosthetic hand has five individually powered fingers, including a powered rotating thumb and an auto-grasp… |
![]() |
New Findings Regarding Cardiovascular Adverse Events wi...
August 1, 2013 - Clinical , Featured By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] – Attention deficit/hyperactivity disorder (ADHD) is a chronic neurological behavior characterized by persistent patterns of inattention and/or hyperactive behavior, resulting in a wide range of emotional, functional, and neurocognitive impairments.1,2 First line therapy for ADHD consists of stimulant medications together with non-pharmacologic interventions, and has been shown to improve… |
![]() |
Drugs and Diseases: The Survival Manual...
August 1, 2013 - Professional Advice / Opinions By: Beatrisa Popovitz, Staff Editor – You may have heard the countless horror stories passed on by upperclassman of how D&Ds seep into the crevices of our brains and take over our psyches to inevitably make us breathe, sleep, and speak pharmacy. Stressing out over exams and investing what may seem like all of your… |
![]() |
Comparison of the New Oral Antithrombotics and Warfarin...
August 1, 2013 - Clinical , Featured By Omar Khalid Pharm.D. Candidate c/o 2014 – The outpour of a multitude of new oral anticoagulants in recent years has health care professionals questioning whether they should switch the patients over, and what new agents should be used. With the recent addition of dabigatran (Pradaxa®) in October 2010, rivaroxaban (Xarelto®) in November 2011, and… |
![]() |
Organ Creation Attempts to Answer Shortage Crisis...
August 1, 2013 - Featured , In the News / Politics By: Efime Popovitz, BS/MD Candidate, Sophie Davis School of Biomedical Education – When Sarah Murnaghan received the long awaited adult lung after years of battling cystic fibrosis, she not only narrowly escaped her death sentence, but also brought to light a plight that thousands of individuals face each day- a struggle for the opportunity to… |
![]() |
DIA 2013 Annual Meeting: Boston, Massachusetts...
August 1, 2013 - Events By: Kristin M. Cheng, PharmD candidate c/o 2014 – The Drug Information Association (DIA) 2013 Annual Meeting took place from June 23rd to June 27th at the Boston Convention and Exhibition Center in Boston, Massachusetts. Twenty-one students from the St. John’s University DIA student chapter attended this year. The purpose of the meeting was… |
![]() |
Two New Agents for the Treatment of Obesity...
August 1, 2013 - Clinical , Featured By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU – Obesity is defined as having a body mass index (BMI) of 30 kg/m2 or greater. It is thought to be the result of an imbalance between energy intake and energy expenditure, possibly due to a number of genetic and environmental factors.1 It is estimated… |
![]() |
Superbug Makes Super Waves in Hospitals Across America...
July 1, 2013 - In the News / Politics By: Beatrisa Popovitz, Staff Editor – For the past decade, antibiotic resistant bacteria have been a growing concern in healthcare. Over the last few months, there has been a great deal of media attention surrounding strains of drug resistant bacteria in hospitals across the United States. Most recently, there has been an increased effort to… |
![]() |
Understanding Opioid Overdose...
July 1, 2013 - Clinical , Featured By: Aleena Cherian, PharmD Candidate c/o 2014 – Although opioid analgesics are among the most effective drugs to treat pain, they are associated with a growing number of public health issues including addiction and severe, often fatal, overdoses. The recent increase in incidences of opioid overdose is directly correlated to rapidly increasing and widespread use… |
![]() |
Solving the HCV Enigma: Current and Future Drug Therapy...
July 1, 2013 - Clinical , Featured By: Tamara Yunusova, Senior Staff Editor – Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are not common, rates of chronic hepatitis C continue to surge due to the recent discovery of the virus in 1989 and consequently, the establishment of a test screening for HCV antibodies in 1992.1 HCV has… |
![]() |
Compounding at a Crossroads: New Boundaries in the Afte...
July 1, 2013 - Featured , In the News / Politics Davidta Brown, PharmD Candidate c/o 2017 – The debate on the nature of compounding practice and the extent to which it ought to be regulated has come to the forefront of public attention. Those who regularly follow American news and politics are familiar with the series of events that have led to the present… |
![]() |
The HIMSS Conference...
July 1, 2013 - Events By: Tina Chang & Helen Dong PharmD Candidates c/o 2014 Ever been to a conference where all you do is tweet all day? That’s exactly what we did at the New York State Healthcare Information and Management Systems Society (HIMSS) conference, where this year’s focus was on the role of health information technology in… |
![]() |
Journey to a PharmD...
July 1, 2013 - Professional Advice / Opinions By: Jacqueline Chirico; Pharm D Candidate c/o 2016 – The reasons behind the choice to study pharmacy here at St. John’s University vary from student to student. Some are interested in helping patients, while others are interested in the science behind how drugs affect the body. For me, it was the experience that I had… |
![]() |
PSSNY Convention...
July 1, 2013 - Events By Taryn Mondiello, PharmD Candidate c/o 2015 – From June 7th to June 9th, pharmacists from all over New York State gathered at the LaGuardia Marriott in East Elmhurst for the 135th annual PSSNY summer convention. The Pharmacists Society of the State of New York, better known as PSSNY, was founded in 1879 and is… |
![]() |
Angelina Jolie’s Double Mastectomy: What it Reveals A...
July 1, 2013 - Professional Advice / Opinions By Sang Hyo Kim, Staff Editor – Angelina Jolie, the actress recognized for her charismatic beauty, revealed to the New York Times that she had undergone double mastectomy, the surgical removal of the breasts. Because her mother died of ovarian cancer at 56, when Jolie learned that she had a mutation in her BRCA1 gene,… |
![]() |
Faculty Spotlight: Dr. Heather Mavronicolas Forges the ...
July 1, 2013 - Featured , Professional Advice / Opinions By: Tasnima Nabi, Content-focused Co-Copy Editor – The College of Pharmacy and Health Sciences has officially launched a Master of Public Health (MPH) degree program and accepted applications for Fall 2013. Public Health has become an increasingly important area of study over the years as our country experiences rising numbers of chronic disease, health care… |
![]() |
Lower Vaccine Costs for Developing Nations...
July 1, 2013 - Featured , In the News / Politics By: Steve Soman, PharmD – India has become a powerhouse in pharmaceutical manufacturing, often supplying generic alternatives at a fraction of the brand name cost to the developing world. Cheaper alternatives make costly drugs more affordable for poorer nations and NGOs.1 Indian manufacturer Biological E. Limited, a biotech firm based in Hyderabad India, signed a… |
![]() |
FDA Takes Major Strides Towards Opioid Abuse Prevention...
June 1, 2013 - Featured , In the News / Politics By: Ada Seldin PharmD Candidate c/o 2015 – On April 16th, 2013, the FDA approved the labeling change for the reformulated OxyContin® (oxycodone hydrochloride controlled-release) tablets, made by Pharma L.P. This change reflects the abuse-deterrent properties of the reformulated OxyContin®, which were not present in the original formulation approved by the FDA in 1995. OxyContin®… |
![]() |
Coffeehouse Chats...
June 1, 2013 - Events By: Ada Seldin and Moisey Rafailov, PharmD Candidates Class of 2015 – The “Coffeehouse Chats” is an annual Rho Chi Society Event that serves as a steppingstone to fostering professional relationships between students and faculty. The event provides a platform for students and professors to exchange experiences and ideas. This year, the event took place… |
![]() |
Helping Solve the Cruel Mystery...
June 1, 2013 - Featured , In the News / Politics By: Erica Dimitropoulos, Senior Staff Editor – Lupus is highly unpredictable and occurs without warning; there is no known cause and no known cure. It affects over 1.5 million Americans, 90% of whom are women between the ages of 15 – 44.1 No two cases of lupus are alike, making it a very difficult disease… |
![]() |
Pay to Delay: The Honest Truth...
June 1, 2013 - Professional Advice / Opinions By: David Ong, Pharm.D. Candidate c/o 2014 – Our current healthcare system receives much criticism from the press as well as the public. Big pharmaceutical companies (“Big Pharma”) have consistently been characterized as part of the problem. Most of the blame for high drug costs is levied on Big Pharma. One of the criticisms is… |
![]() |
FDA Approves Dimethyl Fumarate for Treatment of Relapsi...
June 1, 2013 - Clinical , Featured By: Andy Zhang, PharmD Candidate c/o 2015 – On March 28, 2013, the U.S. Food and Drug Administration announced the approval of Tecfidera™ (dimethyl fumarate) for the treatment of relapsing forms of multiple sclerosis (MS) in adults.1 Tecfidera™ (dimethyl fumarate) will be the third oral drug used for the treatment of MS. The manufacturer Biogen… |
![]() |
Interview with Dr. Omudhome Ogbru, Founder of RxEconsul...
June 1, 2013 - Featured , Professional Advice / Opinions By: Steve Soman, PharmD Candidate c/o 2013 – Q: I see that you got your PharmD at the University of the Pacific. Looking back, what made you choose pharmacy and how has this changed over the years of your practice (if it has)? A: I became a pharmacist because I like to care for others… |
![]() |
Noninvasive Cancer Screening—Will We Ever Get It Righ...
June 1, 2013 - Clinical , Featured By: Frances Sousonis, Candidate c/o 2017 – Unfortunately, cancer is a disease about which many are able to share stories. All too often, beloved persons are diagnosed with cancer, or, more regrettably, loses their battle with the beast. Colon cancer is the third most common cancer in the United States and around 150,000 people each… |
![]() |
Disclosure of Clinical Research Funding: Can Ignorance ...
May 1, 2013 - Professional Advice / Opinions By: Bharat Kirthivasan, Co-Copy Editor [Content-Focused] – Most people would prefer that a research paper be mandated to disclose its source of funds. For example, if a publication effusively supports a certain drug, we want to know if its parent company is footing the bill. Transparency allows research to be viewed in light of its… |
![]() |
Event Review: Relay For Life...
May 1, 2013 - Events By: Rachna Burman & Rodashi Rahman, PharmD Candidate 2016 – Relay for life (Relay) is a volunteer-based fundraiser to support cancer research by the American Cancer Society. Each April, students of St. Johns University participate in this event. Relay is a poignant event in which students who are either directly or indirectly affected by cancer… |